Literature DB >> 11709051

Choosing between growth arrest and apoptosis through the retinoblastoma tumour suppressor protein, Abl and p73.

J Y Wang1, S W Ki.   

Abstract

The choice between growth arrest and apoptosis is made during differentiation, leading to survival with permanent arrest (e.g. neurons), or to death (e.g. epithelium). Genotoxic stress can also cause growth arrest or apoptosis, in addition to the activation of cell cycle checkpoint pathways. The p53 tumour suppressor can simulate growth arrest and apoptosis in response to DNA damage. Thus, p53 alone is not sufficient to specify these two mutually exclusive fates in damaged cells. The retinoblastoma tumour suppressor protein (RB) is a necessary downstream effector in p53-mediated growth arrest. RB inhibits E2F and the nuclear c-Abl tyrosine kinase. Interestingly, E2F activates the transcription of p73 mRNA and c-Abl stabilizes the p73 protein and activates its pro-apoptotic function. Because of RB, the c-Abl/p73 apoptosis pathway is activated in S/G(2) cells but not in G(1) cells. Taken together, the current data suggests RB to be an important player in directing the choice between permanent arrest and apoptosis. The antagonism between RB and c-Abl/p73 may modulate the function of p53 to direct the choice between growth arrest and apoptosis in DNA damaged cells.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11709051     DOI: 10.1042/0300-5127:0290666

Source DB:  PubMed          Journal:  Biochem Soc Trans        ISSN: 0300-5127            Impact factor:   5.407


  9 in total

1.  DNA damage-activated ABL-MyoD signaling contributes to DNA repair in skeletal myoblasts.

Authors:  M Simonatto; F Marullo; F Chiacchiera; A Musaró; J Y J Wang; L Latella; P L Puri
Journal:  Cell Death Differ       Date:  2013-09-20       Impact factor: 15.828

2.  The Ron receptor tyrosine kinase activates c-Abl to promote cell proliferation through tyrosine phosphorylation of PCNA in breast cancer.

Authors:  H Zhao; M-S Chen; Y-H Lo; S E Waltz; J Wang; P-C Ho; J Vasiliauskas; R Plattner; Y-L Wang; S-C Wang
Journal:  Oncogene       Date:  2013-04-01       Impact factor: 9.867

3.  The last CTD repeat of the mammalian RNA polymerase II large subunit is important for its stability.

Authors:  Rob D Chapman; Benoit Palancade; Andreas Lang; Olivier Bensaude; Dirk Eick
Journal:  Nucleic Acids Res       Date:  2004-01-02       Impact factor: 16.971

4.  Characterization of 9-nitrocamptothecin liposomes: anticancer properties and mechanisms on hepatocellular carcinoma in vitro and in vivo.

Authors:  Shunzhen Zheng; Shuang Chang; Jinli Lu; Zhihui Chen; Li Xie; Yu Nie; Bin He; Shengquan Zou; Zhongwei Gu
Journal:  PLoS One       Date:  2011-06-09       Impact factor: 3.240

5.  Decoding the role of the nuclear receptor SHP in regulating hepatic stellate cells and liver fibrogenesis.

Authors:  Sabrina Cipriani; Adriana Carino; Dario Masullo; Angela Zampella; Eleonora Distrutti; Stefano Fiorucci
Journal:  Sci Rep       Date:  2017-01-24       Impact factor: 4.379

Review 6.  The p53 family member p73 in the regulation of cell stress response.

Authors:  Svetlana Zvereva; Aleksandra Dalina; Igor Blatov; Julian M Rozenberg; Ilya Zubarev; Daniil Luppov; Alexander Bessmertnyi; Alexander Romanishin; Lamak Alsoulaiman; Vadim Kumeiko; Alexander Kagansky; Gerry Melino; Carlo Ganini; Nikolai A Barlev
Journal:  Biol Direct       Date:  2021-11-08       Impact factor: 4.540

7.  Differentiation-induced radioresistance in muscle cells.

Authors:  Lucia Latella; Jiri Lukas; Cristiano Simone; Pier Lorenzo Puri; Jiri Bartek
Journal:  Mol Cell Biol       Date:  2004-07       Impact factor: 4.272

8.  c-Abl inhibition delays motor neuron degeneration in the G93A mouse, an animal model of amyotrophic lateral sclerosis.

Authors:  Ryu Katsumata; Shinsuke Ishigaki; Masahisa Katsuno; Kaori Kawai; Jun Sone; Zhe Huang; Hiroaki Adachi; Fumiaki Tanaka; Fumihiko Urano; Gen Sobue
Journal:  PLoS One       Date:  2012-09-25       Impact factor: 3.240

9.  Imatinib prevents beta cell death in vitro but does not improve islet transplantation outcome.

Authors:  Aileen J F King; Lisa A Griffiths; Shanta J Persaud; Peter M Jones; Simon L Howell; Nils Welsh
Journal:  Ups J Med Sci       Date:  2016-03-08       Impact factor: 2.384

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.